Risk Factors for COVID-19 Severity: Meta-Analysis Approach
Purnami S.W., Susilorini, Cahyaningrum F.C., Iwang Y.
Abstract
Objective Coronavirus is a new type of virus that causes COVID-19 where the disease causes a fatal impact on sufferers. This study aimed to explore risk factors against the severity of COVID-19, i.e. dyspnea, cough, fever, diarrhea, history of diabetes, hypertension, Chronic Obstructive Pulmonary Disease (COPD), impaired liver function, and Cardiovascular Disease (CVD). Materials and Methods: The author conducted a study search on Friday, March 27th, 2020 at 07.00 – 08.30 PM through the PubMed website. The study search strategy uses the keywords of “COVID-19” or “corona virus”, “symptoms”, “clinical”, “severe”, and other words related to COVID-19. Studies used for meta-analysis must meet inclusion and exclusion criteria. Results and Discussion: Meta-analysis results for significant risk factors include: dyspnea (OR=3.53, 95% CI: 2.62-4.75), diarrhea (OR=1.73, 95% CI: 1.03-2.89), history of diabetes (OR=2.65, 95% CI: 1.77-3.98), hypertension (OR=2.25, 95% CI: 1.64-3.08), COPD (OR=6.26, 95% CI: 2.47-15.87), and CVD (OR=2.84, 95% CI: 1.64-4.90). Conclusion Patients who have dypsnee and diarrhea symptoms have higher riks of falling into severy COVID. Risk factors for cough symptoms, fever symptoms, and history of impaired liver function are not related to the severity of COVID-19. Patients with comorbidity such as diabetes, hypertension, COPD dan CVD have higher risk to get severe COVID-19.
Management issues with infection control during trauma resuscitation in the era of covid-19: South african experience.
Ganchi F., Hardcastle T.C., Hollander D.D., Naidoo S., Shangase T.N.
Agreement Between Nurses’ Anxiety And Depression Levels And Their Compliance With Isolation Measures During The Covid 19 Pandemic: An Online Cross-Sectional Study
Aydin Sayilan A., Demir Dogan M., Sayilan S.
Ibn tofail’suniversity students’ satisfaction evaluation towards distance learning and its impacts on the students’ mental health during the covid 19 confinement
Abidli Z., Aouane E., Chaouch A., Elhamzaoui M., Jabari K., Khohmimidi A., Rahali K., Seghiri R.
Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling
Sajdel-Sulkowska E.M.
Dynamics of the Microbiota and Its Relationship with Post-COVID-19 Syndrome
De Jesus-Gonzalez L.A., Leon-Juarez M., Leon-Reyes G., Lopez-Ortega O., Martinez-Castillo M., Moreno-Corona N.C., Perez-Martinez C.A.
No Title
Impact of COVID-19 and Antibiotic Treatments on Gut Microbiome: A Role for Enterococcus spp.
Gorska A., Ivaldi F., Lambertenghi L., Mirandola M., Righi E., Sartor A., Sciammarella C., Tacconelli E.
The aging gut microbiome and its impact on host immunity
Bosco N., Noti M.
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
Chan F.K.L., Chan P.K.S., Chan V., Cheung C.P., Chow K.M., Chung A.C.K., Fung K.S.C., Hui D.S.-C., Joynt G., Li A.Y.L., Li T.C.-M., Ling L., Liu Q., Lui G.C.-Y., Ng R.W.Y., Ng S.C., Ng S.S.S., Tso E.Y.K., Wong C.K., Wong G.L.-H., Yeoh Y.K., Yip T.C.F., Zhang F., Zuo T.
Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral–bacterial interactions
Kruglikov I.L., Scherer P.E., Shah M.
